Mei-Yin Polley to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Mei-Yin Polley has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.386
-
Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicities. Stat Med. 2011 Jul 30; 30(17):2130-43.
Score: 0.358
-
Immunotherapy and radiation therapy: considerations for successfully combining radiation into the paradigm of immuno-oncology drug development. Radiat Res. 2014 Aug; 182(2):252-7.
Score: 0.028